Douglas Fisher

Douglas Fisher

Corporate Officer/Principal bei SERA PROGNOSTICS, INC.

Vermögen: 170 263 $ am 31.03.2024

48 Jahre
Health Technology
Health Services
Finance

Profil

Doug joined InterWest's healthcare team in 2009, focusing on biopharmaceutical, diagnostic and medical device investments, and portfolio company support.
He is a board member of Gynesonics and Indi Molecular and a former board member of Lycera, Obalon Therapeutics (NASDAQ: RSLS, acquired by ReShape Lifesciences) and PMV Pharma (NASDAQ GS: PMVP).
Doug is also actively involved in InterWest's investments in PMV Pharma (NASDAQ GS: PMVP), Potenza Therapeutics, Sera Prognostics (NASDAQ: SERA, where he serves as the Chief Business Officer), and Tizona Therapeutics.
Prior to joining InterWest, Doug was a vice president at New Leaf Venture Partners where he spent three years focusing on biopharmaceutical, medical device, and diagnostics investments.
He was involved with several investments, including Pearl Therapeutics, Interlace Medical (Acquired by Hologic), and Stromedix (Acquired by Biogen Idec).
Prior to joining New Leaf, Doug was a project leader with The Boston Consulting Group where he was a member of the Health Care Practice Area, consulting for leading pharmaceutical and biotech companies.
Previously, he worked for Centocor (a J&J operating company) in the Global Biologic Strategic Marketing Group.
Doug received an A.B.
in economics with honors and distinction, and a B.S.
in biology with distinction, from Stanford, where he graduated Phi Beta Kappa.
He has an M.D.
from the University of Pennsylvania School of Medicine and an M.B.A.
from Wharton, where he graduated with honors as a Siebel Scholar and Palmer Scholar.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
0,29%
14.02.2024 43 300 ( 0,29% ) 132 931 $ 31.03.2024
27.10.2023 5 572 ( 0,39% ) 37 332 $ 31.03.2024

Aktive Positionen von Douglas Fisher

UnternehmenPositionBeginn
SERA PROGNOSTICS, INC. Corporate Officer/Principal 29.04.2015
Founder -
Private Equity Investor 21.08.2020
Weavr Health Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Alle aktiven Positionen von Douglas Fisher

Ehemalige bekannte Positionen von Douglas Fisher

UnternehmenPositionEnde
░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Douglas Fisher im Detail an

Ausbildung von Douglas Fisher

Stanford University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin
Perelman School of Medicine Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Douglas Fisher im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

25

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
SERA PROGNOSTICS, INC.

Health Services

PMV PHARMACEUTICALS, INC.

Commercial Services

PRECIPIO, INC.

Health Services

Private Unternehmen19

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Services

Health Services

Health Technology

Health Technology

Commercial Services

Finance

Finance

Health Technology

Electronic Technology

Finance

Finance

Weavr Health

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Douglas Fisher